Aug 13, 2026 04:01PM
Jul 28, 2026 08:34AM
Jul 28, 2026 08:34AM
Jul 1, 2026 08:55AM
Jun 25, 2026 09:05AM
Jun 25, 2026 09:05AM
Jun 4, 2026 08:02AM Dare Bioscience launches Flora Sync LF5 vaginal probiotic capsules
Jun 4, 2026 08:00AM
May 26, 2026 08:01AM
May 26, 2026 08:00AM
May 18, 2026 08:01AM
May 18, 2026 08:00AM
May 14, 2026 04:01PM
May 12, 2026 08:01AM Daré Bioscience reports interim Phase 3 results for hormone-free contraceptive
May 12, 2026 08:00AM
Mar 26, 2026 04:01PM
Mar 23, 2026 08:00AM
Mar 16, 2026 08:02AM
Mar 16, 2026 08:00AM
Mar 12, 2026 08:00AM
Feb 23, 2026 08:01AM Dare Bioscience gets FDA clearance for HPV treatment phase 2 trial
Feb 23, 2026 08:00AM
Feb 11, 2026 08:00AM
Dec 10, 2025 08:01AM
Dec 10, 2025 08:00AM
Dec 2, 2025 06:44AM
Dec 1, 2025 08:03AM
Dec 1, 2025 08:00AM Daré Bioscience Announces Return of Rights to Ovaprene®; Phase 3 Program Ongoing; Positive Interim Data and Grant Funding Position Asset for Value-Maximization
Nov 24, 2025 08:01AM
Nov 24, 2025 08:00AM
Nov 13, 2025 04:01PM
Nov 11, 2025 08:00AM
Oct 6, 2025 08:03AM
Oct 6, 2025 08:00AM
Sep 24, 2025 08:00AM Daré Bioscience to Receive up to $499,000 to Support Preeclampsia Research
Aug 14, 2025 04:01PM
Aug 7, 2025 08:00AM
Jul 29, 2025 08:00AM
Jul 21, 2025 01:47PM
Jul 21, 2025 08:00AM
Jul 15, 2025 07:16AM
Jul 14, 2025 08:03AM Daré Bioscience reports interim Phase 3 results for hormone-free contraceptive
Jul 14, 2025 08:00AM
Jul 11, 2025 08:00AM
Jul 11, 2025 08:00AM
Jun 12, 2025 05:00PM
Jun 4, 2025 08:01AM
Jun 4, 2025 08:00AM
May 13, 2025 04:01PM Daré Bioscience Reports First Quarter 2025 Financial Results and Provides Company Update
May 6, 2025 08:00AM

328,605 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All